- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-06-0001463

About Prolife Industries Limited
Data last updated:
Prolife Industries Limited is a public limited company based in Ankleshwar, Gujarat, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 27 July 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN L24231GJ1994PLC022613. Its GSTIN is 24AAACR9172R1ZP (Gujarat). It is a listed company as per MCA records. Its shares are listed on NSE: PROLIFE.
The company has an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹4.09 Cr. It was formerly known as Mamta Dyes and Intermediates Private Limited and R R J-Dyes and Intermediates Limited. It is led by directors including Karan Manindersingh Jolly (Managing Director) and Anureet Kaur Jolly.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 213 G.I.D.C. Panoli, Ankleshwar, Gujarat, India – 394116.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹54.52 Cr, a decline of 1.7% compared to the previous year. For the same year it recorded a net profit of ₹4.26 Cr (net margin 7.8%) and EBITDA of ₹4.1 Cr (EBITDA margin 7.5%). The net worth stands at ₹49.6 Cr (up 9.1% YoY). Total assets are valued at ₹50.66 Cr (up 4.2% YoY).
The company has about 60 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Prolife Industries. As per MCA filings, the company has satisfied charges of ₹18.75 Cr on record. Court records list 6 cases involving the company, including 5 filed by the company and 1 filed against it. The company has 9 deals on record (8 market trades, 1 ipo); the latest was in December 2022. Its 6 peer companies in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Shanti Inorganics Limited with revenue of ₹58.48 Cr. The company has 1 MSME Form 1 return on record, listing 8 overdue payments to 8 micro and small suppliers.
Prolife Industries Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-06-0001463). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website prolifeindustries.in.
Company details
Name history
Prolife Industries has undergone 2 name changes throughout its history. The company was previously known as Mamta Dyes And Intermediates Private Limited, and R R J-Dyes And Intermediates Limited. The current legal name is Prolife Industries Limited.
| Company Name | Status |
|---|---|
| Prolife Industries Limited | Current |
| Mamta Dyes And Intermediates Private Limited | Previous |
| R R J-Dyes And Intermediates Limited | Previous |
CIN history
Prolife Industries has one previous CIN (Corporate Identification Number): U24231GJ1994PLC022613. The current CIN is L24231GJ1994PLC022613, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24231GJ1994PLC022613 | Current |
| U24231GJ1994PLC022613 | Previous |
Recognitions & Rankings of Prolife Industries
Contact details
Prolife Industries Limited's registered office is in Ankleshwar, Gujarat. Its website is prolifeindustries.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address213 G.I.D.C. Panoli, Ankleshwar, Gujarat, India – 394116
- IndustryChemicals and Materials, Industrial Chemicals
To see the full contact details of Prolife Industries Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Prolife Industries operates one associated brand: Prolife Industries. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Special intermediates for dyes, pigments, pharmaceuticals, and agrochemicals are manufactured. | prolifeindustries.in |
Business activity
The main business activity of Prolife Industries is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Prolife Industries Limited, buy the company report.
Financials of Prolife Industries Limited
FY 2025-26 filings availableProlife Industries Limited reported revenue of ₹54.52 Cr (down 1.7% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 54.52 | 55.47 | 56.82 | 78.31 | 73.20 | 73.59 | 50.45 |
| Revenue growth | -1.7% | -2.4% | -27.4% | +7.0% | -0.5% | +45.9% | - |
| EBITDA | 4.10 | 5.67 | 11.80 | 8.74 | 5.98 | 8.22 | 5.57 |
| EBITDA margin | +7.5% | +10.2% | +20.8% | +11.2% | +8.2% | +11.2% | +11.0% |
| Profit before tax | 5.87 | 6.31 | 11.85 | 9.24 | 5.97 | 7.39 | 5.69 |
| Net profit | 4.26 | 4.68 | 8.75 | 6.92 | 4.30 | 5.42 | 4.00 |
| Net profit margin | +7.8% | +8.4% | +15.4% | +8.8% | +5.9% | +7.4% | +7.9% |
| EPS (₹) | 10.39 | 11.43 | 21.40 | 16.89 | 10.51 | 13.43 | 9.87 |
| Balance sheet | |||||||
| Total assets | 50.66 | 48.64 | 45.32 | 34.74 | 30.83 | 27.38 | 24.17 |
| Net worth | 49.60 | 45.47 | 40.99 | 32.36 | 25.57 | 21.39 | 16.01 |
| Total debt | 0.27 | 2.58 | 3.81 | 1.92 | 4.71 | 5.49 | 7.71 |
| Cash & bank | 16.14 | 17.44 | 21.57 | 1.46 | 1.37 | 0.83 | 2.68 |
| Net working capital | 32.52 | 28.06 | 26.09 | 11.58 | 5.08 | 3.58 | 5.13 |
| Cash flow | |||||||
| Cash from operations | (1.64) | (1.25) | 17.33 | 0.05 | 3.73 | 5.11 | 10.02 |
| Cash from investing | 2.66 | (1.18) | 3.49 | 1.46 | (3.05) | (5.64) | (4.69) |
| Cash from financing | (2.32) | (1.69) | (0.72) | (1.43) | (0.14) | (1.31) | (3.74) |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 54.52 | 55.47 | 56.82 | 78.31 | 73.20 | 73.59 | 50.45 |
| Revenue growth | -1.7% | -2.4% | -27.4% | +7.0% | -0.5% | +45.9% | - |
| Other income | 2.84 | 2.08 | 1.59 | 2.18 | 1.63 | 0.62 | 1.78 |
| Total expenses | 50.42 | 49.80 | 45.02 | 69.57 | 67.22 | 65.37 | 44.88 |
| Employee cost | 4.74 | 4.30 | 3.50 | 3.58 | 3.28 | 2.86 | 1.80 |
| EBITDA | 4.10 | 5.67 | 11.80 | 8.74 | 5.98 | 8.22 | 5.57 |
| EBITDA margin | +7.5% | +10.2% | +20.8% | +11.2% | +8.2% | +11.2% | +11.0% |
| Depreciation | 0.98 | 1.10 | 1.21 | 1.25 | 1.16 | 0.93 | 1.03 |
| Interest | 0.09 | 0.34 | 0.33 | 0.43 | 0.48 | 0.52 | 0.63 |
| Profit before tax | 5.87 | 6.31 | 11.85 | 9.24 | 5.97 | 7.39 | 5.69 |
| Tax | 1.61 | 1.63 | 3.10 | 2.32 | 1.67 | 1.89 | 1.64 |
| Net profit | 4.26 | 4.68 | 8.75 | 6.92 | 4.30 | 5.42 | 4.00 |
| Net profit margin | +7.8% | +8.4% | +15.4% | +8.8% | +5.9% | +7.4% | +7.9% |
| EPS (₹) | 10.39 | 11.43 | 21.40 | 16.89 | 10.51 | 13.43 | 9.87 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 |
| Reserves & surplus | 45.51 | 41.38 | 36.90 | 28.27 | 21.48 | 17.30 | 11.92 |
| Shareholders' funds (net worth) | 49.60 | 45.47 | 40.99 | 32.36 | 25.57 | 21.39 | 16.01 |
| Secured loans | 0.00 | 0.00 | 0.00 | (2.21) | (0.22) | 0.96 | 2.44 |
| Unsecured loans | 0.27 | 2.58 | 3.81 | 4.13 | 4.93 | 4.53 | 5.27 |
| Total debt | 0.27 | 2.58 | 3.81 | 1.92 | 4.71 | 5.49 | 7.71 |
| Total liabilities | 50.66 | 48.64 | 45.32 | 34.74 | 30.83 | 27.38 | 24.17 |
| Assets | |||||||
| Gross block | 21.02 | 20.33 | 20.00 | 18.86 | 17.68 | 14.43 | 13.76 |
| Net block | 10.22 | 10.52 | 11.29 | 11.36 | 11.43 | 9.34 | 9.60 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 1.21 | 1.21 | 1.21 | 1.21 | 1.22 | 1.22 | 1.22 |
| Inventories | 9.39 | 6.73 | 5.59 | 5.79 | 11.42 | 7.92 | 6.49 |
| Sundry debtors | 10.72 | 8.46 | 5.36 | 10.61 | 16.77 | 15.80 | 7.20 |
| Cash & bank balances | 16.14 | 17.44 | 21.57 | 1.46 | 1.37 | 0.83 | 2.68 |
| Loans & advances | 0.00 | 0.12 | 0.17 | 0.13 | 0.11 | 0.28 | 0.25 |
| Total current assets | 36.25 | 32.75 | 32.69 | 17.99 | 29.67 | 24.83 | 16.62 |
| Total current liabilities | 3.73 | 4.69 | 6.60 | 6.41 | 24.59 | 21.25 | 11.49 |
| Net working capital | 32.52 | 28.06 | 26.09 | 11.58 | 5.08 | 3.58 | 5.13 |
| Total assets | 50.66 | 48.64 | 45.32 | 34.74 | 30.83 | 27.38 | 24.17 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 17.44 | 21.57 | 1.46 | 1.37 | 0.83 | 2.68 | 1.09 |
| Net cash from operating activities | (1.64) | (1.25) | 17.33 | 0.05 | 3.73 | 5.11 | 10.02 |
| Net cash from investing activities | 2.66 | (1.18) | 3.49 | 1.46 | (3.05) | (5.64) | (4.69) |
| Net cash from financing activities | (2.32) | (1.69) | (0.72) | (1.43) | (0.14) | (1.31) | (3.74) |
| Net change in cash | (1.31) | (4.12) | 20.11 | 0.08 | 0.54 | (1.84) | 1.58 |
| Closing cash | 16.14 | 17.44 | 21.57 | 1.46 | 1.37 | 0.83 | 2.68 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -1.7% | -2.4% | -27.4% | +7.0% | -0.5% | +45.9% | - |
| EBITDA growth | -27.7% | -52.0% | +35.0% | +46.2% | -27.3% | +47.6% | - |
| PBT growth | -7.0% | -46.8% | +28.3% | +54.8% | -19.2% | +29.9% | +101.8% |
| Net income growth | -9.0% | -46.5% | +26.5% | +60.9% | -20.7% | +35.5% | - |
| Revenue CAGR (3Y) | -11.4% | -8.8% | -8.3% | +15.8% | +35.1% | +39.2% | +22.9% |
| EBITDA CAGR (3Y) | -22.3% | -1.8% | +12.8% | +16.2% | +12.5% | +32.6% | +30.3% |
| Profitability & leverage | |||||||
| Net income margin | +7.8% | +8.4% | +15.4% | +8.8% | +5.9% | +7.5% | +8.0% |
| Return on capital employed | +12.0% | +14.2% | +30.5% | +29.5% | +22.2% | +30.7% | +28.8% |
| Return on net worth | +8.9% | +10.8% | +23.9% | +23.9% | +18.3% | +29.4% | +28.7% |
| Debt / equity | 0.03 | 0.07 | 0.08 | 0.11 | 0.22 | 0.35 | 0.53 |
| Long-term debt / equity | 0.03 | 0.07 | 0.11 | 0.16 | 0.20 | 0.26 | 0.48 |
| Interest cover | 2.88 | 7.44 | 3.12 | 5.74 | 9.96 | 7.13 | 13.88 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 2.64 | 2.75 | 2.92 | 4.29 | 4.56 | 5.22 | 3.75 |
| Inventory turnover | 6.76 | 9.00 | 9.99 | 9.10 | 7.57 | 10.21 | 11.93 |
| Debtors turnover | 5.69 | 8.03 | 7.12 | 5.72 | 4.49 | 6.40 | 6.58 |
| EPS (₹) | 10.39 | 11.43 | 21.40 | 16.89 | 10.51 | 13.43 | 9.87 |
| Dividend per share (₹) | 0.30 | 0.30 | 0.50 | 0.30 | 0.30 | 0.30 | 0.30 |
| Book value per share (₹) | 121.16 | 111.07 | 100.14 | 79.04 | 62.46 | 52.25 | 39.12 |
To see the full year-wise statements and ratios of Prolife Industries Limited, buy the company report.
Board of directors of Prolife Industries Limited
Prolife Industries has 6 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anureet Kaur Jolly Also directs: Prolife Fine and Specialty Chemicals LLP, Yushka Cosmetics LLP, Prolife Chemopharma Private Limited and 5 more | Director | 31 Oct 2009 | 17 Years 0 Months | Current |
| Dharmendra Mahendra Pushkarna | Director | 11 Apr 2019 | 7 Years 7 Months | Current |
| Veljibhai Kanjibhai Patel | Director | 17 Mar 2020 | 6 Years 7 Months | Current |
| Karan Manindersingh Jolly Also directs: Prolife Fine and Specialty Chemicals LLP, Yushka Cosmetics LLP, Prolife Chemopharma Private Limited and 5 more | Managing Director | 11 Apr 2019 | 7 Years 7 Months | Current |
| Keshavkumar Bipinkumar Singh | Director | 10 Nov 2020 | 6 Years 0 Months | Current |
| Siddharth Raghuvanshi Also directs: Yushka Cosmetics LLP, Prolife Speciality Chemicals Limited, Cosmolife Foods and Processing Private Limited and 1 more | Director | 10 Nov 2020 | 6 Years 0 Months | Current |
Peer comparison
Prolife Industries Limited is compared with the 6 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shanti Inorganics Limited | ₹58.48 Cr (FY 2025) | 30.0% | Ahmedabad, Gujarat, India | |||
| Cognizant Chemical Private Limited | ₹57.9 Cr (FY 2024) | 31.0% | Kalamboli, Maharashtra, India | |||
| Chemie Products Pvt Ltd | ₹57.77 Cr (FY 2024) | -2.0% | Khushkhera, Rajasthan, India | |||
| Samrat Remedies India Private Limited | ₹57.12 Cr (FY 2024) | 29.0% | Mumbai, Maharashtra, India | |||
| Bharat Carbonates Private Limited | ₹57.07 Cr (FY 2025) | 20.0% | Surat, Gujarat, India | |||
| Unicon Fibro Chemicals Pvt Ltd | ₹56.59 Cr (FY 2025) | 16.0% | Mumbai, Maharashtra, India | |||
| Prolife Industries Limitedthis company | ₹54.52 Cr (FY 2026) | ₹4.26 Cr | 7.8% | -1.7% | 60 | Ankleshwar, Gujarat, India |
To see the full peer comparison of Prolife Industries Limited, buy the company report.
Auditor
Prolife Industries Limited is audited by BIHARI SHAH & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BIHARI SHAH & CO. | FY 2023 | 119020W |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 73.70%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 26.30%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 73.70% | 73.70% | 73.70% | 73.70% |
| Public | 26.30% | 26.30% | 26.30% | 26.30% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jun 2022 | 100591858 | Others | ₹6.5 Cr | Satisfied | |
| 31 May 2005 | 90096972 | Others | ₹6.12 Cr | Satisfied | |
| 31 May 2005 | 90100050 | Others | ₹6.12 Cr | Satisfied |
To see the full charge records of Prolife Industries Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Prolife Industries Limited has 9 deals on record (8 market trades, 1 ipo); the latest was in December 2022.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2022 | Market trade | ₹49.8 Lakh | Seller: an individual |
| Jan 2021 | Market trade | ₹14.7 Lakh | Buyer: an individual |
| Dec 2020 | Market trade | ₹9.9 Lakh | Buyer: an individual Seller: an individual |
| Jul 2020 | Market trade | ₹17.8 Lakh | Buyer: As Finalysis Ventures LLP , an individual Seller: Ram Babu Kabra Huf |
| Jan 2019 | Market trade | ₹8.7 Lakh | Buyer: an individual Seller: Viram Suvarn Limited |
To see the full deal history of Prolife Industries Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Prolife Industries Limited has 6 court cases on record: 5 filed by Prolife Industries, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 0 |
| District courts | 2 | 1 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Special civil application | Filed by the company against , Ahmedabad and 1 other | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against The Income Tax Officer Ward-3( | Disposed |
| High Court, GUJARAT | Special civil application | Filed by the company against individuals | Disposed |
| District court, Bharuch, Gujarat | Court case (RECO33C2 LC) | Filed against the company by an individual | Disposed |
| District court, Bharuch, Gujarat | Criminal miscellaneous application | Filed by the company against The State of Gujarat | Disposed |
To see the full case history of Prolife Industries Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Prolife Industries Limited has 1 MSME Form 1 return on record, listing 8 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 8)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Trikaldarshi Chemical Industries | |||
| an individual supplier | |||
| an individual supplier | |||
| Gayatri Chemsynth Private Limited |
To see the full MSME payment records of Prolife Industries Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Prolife Industries Limited has a workforce of 60 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 60 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Prolife Industries Limited, buy the company report.
GST
Prolife Industries has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACR9172R1ZP | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Prolife Industries Limited, buy the company report.
Recent activity
Prolife Industries Limited has 26 board changes on record since 1994: 16 appointments and 10 cessations. The latest: Arun Sehgal ceased to be Director on 25 Sep 2022.
26 earlier events are in the company report.
Frequently asked questions
Prolife Industries is an active public limited company based in Ankleshwar, Gujarat, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 27 July 1994 (32+ years old) and is registered under CIN L24231GJ1994PLC022613. Listed on NSE: PROLIFE.
Prolife Industries reported revenue of ₹54.52 Cr for FY 2025-26 (down 1.7% YoY) based on standalone financials.
Prolife Industries has 6 current directors:
- Karan Manindersingh Jolly - Managing Director
- Anureet Kaur Jolly - Director
- Dharmendra Mahendra Pushkarna - Director
- Veljibhai Kanjibhai Patel - Director
- Keshavkumar Bipinkumar Singh - Director
- Siddharth Raghuvanshi - Director
The latest financial statements of Prolife Industries on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 23 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Prolife Industries is 24AAACR9172R1ZP, registered in Gujarat.
The CIN (Corporate Identification Number) of Prolife Industries is L24231GJ1994PLC022613. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. Prolife Industries is a listed company as per MCA records. Its shares are listed on NSE (symbol: PROLIFE).
Prolife Industries has 6 court cases on record: 5 filed by the company and 1 filed against it. Most are in the high courts.
Prolife Industries was incorporated on 27 July 1994, making it 32+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Prolife Industries has 9 deals on record (8 market trades, 1 ipo); the latest was in December 2022.
The peers of Prolife Industries by revenue are Shanti Inorganics Limited, Cognizant Chemical Private Limited, Chemie Products Pvt Ltd, Samrat Remedies India Private Limited, Bharat Carbonates Private Limited and 1 more, all in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Arun Sehgal ceased to be Director on 25 Sep 2022. Manindersingh Satnamsingh Jolly ceased to be Managing Director on 26 Apr 2021. Keshavkumar Bipinkumar Singh was appointed as Director on 10 Nov 2020. Prolife Industries has 26 board changes on record in total.

